Euroapi: Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline
Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 ...
manilatimes19h
Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline
Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...
FiercePharma21h
Sinusitis data from Amgen, AZ's Tezspire spark 'best-in-disease' talk amid Sanofi, GSK competition
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...
The Pharma Letter1h
Kyorin offers Novartis timely new weapon in urticaria
Japan’s Kyorin Pharmaceutical has entered into a global license agreement with Swiss pharma giant Novartis relating to ...
The Pharma Letter1h
FDA removes heart risk warning from testosterone products
The US Food and Drug Administration has issued new labeling changes for all approved testosterone replacement therapy ...
I Went to the Health Industry’s PR Awards. Luigi Mangione Wasn’t the Only One Haunting the Night.
Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...